FDA Drug Application (202235) for IBANDRONATE SODIUM by SAGENT PHARMS

Back to FDA Applications sponsored by SAGENT PHARMS

Application Number202235
Product Number001
FormINJECTABLE;INTRAVENOUS
DosageEQ 3MG BASE/3ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameIBANDRONATE SODIUM
Active IngredientIBANDRONATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient IBANDRONATE SODIUM2


Back to FDA Applications sponsored by SAGENT PHARMS